3M China Expands Shanghai Plants To Increase Medical-Device Presence
This article was originally published in PharmAsia News
Executive Summary3M company's Chinese unit, 3M China, opened a pair of facilities in China aimed at giving it a local supply chain for the medical devices it hopes to sell in the growing Chinese market. 3M China says it is investing $102.5 million in changing over the two plants in Shanghai. Its Asia Pacific Production Facility for Medical Devices plant, already 3M's largest in the Asia-Pacific region, is being expanded. 3M expects the plant to produce 40 percent for sale in China, the rest exported to other countries in Asia. (Click here for more
You may also be interested in...
To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.
Glenmark can sell its partnered generic rival to GSK’s Seretide Accuhaler dry powder inhaler in certain European markets following a settlement with the UK company. The Indian firm has also shelved divestment plans for its API business, at least for now.
Nearly 500 shipments of illegal and unapproved prescription drugs and combination medical devices were seized at US borders thanks to Operation Broadsword.